|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/343 | (2006.01) |
| A61K 31/343 | (2013.01) | ||
| A61P 25/20 | (2006.01) | ||
| A61P 25/20 | (2018.01) | ||
| C12Q 1/6883 | (2018.01) | ||
| C12Q 1/6883 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| C12Q2600/156 | (2013.01) | ||
| C12Q2600/106 | (2013.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 4186502 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 23152614.6 |
| Europos patento paraiškos padavimo data | 2020-02-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-05-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-09-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201962805057 P | 2019-02-13 | US |
| (72) |
POLYMEROPOULOS, Mihael , US
SMIESZEK, Sandra , US
|
| (73) |
Vanda Pharmaceuticals Inc. ,
2200 Pennsylvania Ave NW
Suite 300E, Washington, DC 20037,
US
|
| (54) | TASIMELTEON FOR USE FOR IMPROVING SLEEP |
| TASIMELTEON FOR USE FOR IMPROVING SLEEP |